Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “α-synucleinopathy”

22 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 22 results

Testing effectiveness (Phase 2)UnknownNCT05506891
What this trial is testing

Efficacy and Safety of Astragalus for Non-motor Symptoms of α-Synucleinopathy

Who this might be right for
Parkinsonism
Fujian Medical University Union Hospital 40
Not applicableLooking for participantsNCT06941012
What this trial is testing

Validation of α-synuclein Modifications in Parkinson's dIsoRder Evolution

Who this might be right for
Parkinson Disease (PD)
Casa di Cura IGEA 1,200
Not applicableStudy completedNCT01380899
What this trial is testing

Usefulness of α-synuclein as a Marker for Early Diagnosis of Parkinson's Disease in Skin Biopsy.

Who this might be right for
Parkinson DiseaseParkinsonian Disorders
Universidad Autonoma de San Luis Potosí 87
Not applicableWithdrawnNCT04266457
What this trial is testing

Establishing Alpha-synuclein RT-QuIC Assay as a Diagnostic Technique in REM Sleep Behaviour Disorder

Who this might be right for
Sleep Disorder Rem Sleep BehaviorParkinson's Disease, Lewy Body
University of Edinburgh
Not applicableStudy completedNCT05638815
What this trial is testing

An Observational Study of Parkinson's Disease and Other Synucleinopathies (EASE-PD)

Who this might be right for
Parkinson's DiseaseMultiple System Atrophy
SciNeuro 89
Very early researchLooking for participantsNCT07348250
What this trial is testing

Open-label Study to Evaluate Brain α-Synuclein Deposition Using PET and [18F]MK-0947 in Parkinson's Disease

Who this might be right for
Parkinson's Disease (PD)Parkinson's DiseaseParkinson's Disease (Disorder)
Invicro 22
Not applicableLooking for participantsNCT06890377
What this trial is testing

Targeted Α-synuclein PET Imaging in the Diagnosis of Multiple System Atrophy

Who this might be right for
Multiple System Atrophy - Cerebellar Subtype (MSA-C)Multiple System Atrophy - Parkinsonian Subtype (MSA-P)
Min Zhao,MD 90
Not applicableUnknownNCT05757804
What this trial is testing

Study of 18F-0502B PET Imaging Targeting α-synuclein in the Diagnosis of α-synuclein-related Diseases

Who this might be right for
Positron-Emission TomographyAlpha Synuclein Pathology
Huashan Hospital 20
Not applicableStudy completedNCT06738862
What this trial is testing

[18F] - FD17 PET Imaging of α-synuclein: A Clinical Study in α-synucleinopathy Patients

Who this might be right for
α-synucleinopathyParkinson's Disease (PD)Multiple System Atrophy+2 more
Ruijin Hospital 55
Not applicableLooking for participantsNCT06949670
What this trial is testing

Alpha-Synuclein PET/CT in Various α-Syn-Related Disease

Who this might be right for
Alpha Synuclein PathologyAlpha-SynucleinParkinson Disease
Tianjin Medical University 500
Not applicableLooking for participantsNCT05527067
What this trial is testing

A Registered Cohort Study on α-Synucleinopathy

Who this might be right for
α-synucleinopathy
Fujian Medical University Union Hospital 500
Not applicableLooking for participantsNCT05353881
What this trial is testing

Prodromal Markers in Recurrent Dream Enactment Behaviors Without REM Sleep Without Atonia

Who this might be right for
REM Sleep Behavior Disorder
Chinese University of Hong Kong 102
Large-scale testing (Phase 3)UnknownNCT03858270
What this trial is testing

Inhibition of α-synuclein Cell-cell Transmission by NMDAR Blocker, Memantine

Who this might be right for
Parkinson Disease
Wayne State University 50
Not applicableUnknownNCT04048603
What this trial is testing

Search for Biomarkers of Neurodegenerative Diseases in Idiopathic REM Sleep Behavior Disorder

Who this might be right for
REM Sleep Behavior DisorderNeurodegeneration
Chinese University of Hong Kong 182
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07055087
What this trial is testing

Prevent Cognitive Decline in GBA-associated Parkinson's Disease

Who this might be right for
Parkinson's Disease
University Hospital Tuebingen 120
Early research (Phase 1)Study completedNCT02281474
What this trial is testing

Nilotinib in Cognitively Impaired Parkinson Disease Patients 001

Who this might be right for
Parkinson's DiseaseParkinson's Disease DementiaDiffuse Lewy Body Disease
Georgetown University 12
Very early researchLooking for participantsNCT06891703
What this trial is testing

[18F]ACI-15916 PET in α-synucleinopathies

Who this might be right for
Parkinson's Disease (PD)Multiple System Atrophy (MSA)Dementia With Lewy Bodies (DLB)
AC Immune SA 46
Not applicableStudy completedNCT04700722
What this trial is testing

Synuclein-One Study

Who this might be right for
Parkinson DiseaseMultiple System AtrophyDementia With Lewy Bodies+1 more
CND Life Sciences 428
Not applicableStudy completedNCT03671772
What this trial is testing

Progression of Prodromal Markers of α-synucleinopathy Neurodegeneration in the FDRs of Patients With RBD

Who this might be right for
REM Sleep Behavior DisorderNeurodegeneration
Chinese University of Hong Kong 170
Early research (Phase 1)Looking for participantsNCT07157345
What this trial is testing

Testing if PDR-001 Can Safely and Effectively Remove Harmful Brain Protein in Parkinson's Disease

Who this might be right for
Parkinson Disease (PD)
Ruijin Hospital 12
Load More Results